ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 80 filers reported holding ENANTA PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $36,000 | -5.3% | 720 | -2.7% | 0.00% | 0.0% |
| Q1 2020 | $38,000 | -17.4% | 740 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $46,000 | +4.5% | 740 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $44,000 | 0.0% | 740 | +42.3% | 0.00% | +100.0% |
| Q2 2019 | $44,000 | -12.0% | 520 | 0.0% | 0.00% | -50.0% |
| Q1 2019 | $50,000 | -61.2% | 520 | -71.4% | 0.00% | -60.0% |
| Q4 2018 | $129,000 | -25.4% | 1,820 | -9.9% | 0.01% | 0.0% |
| Q3 2018 | $173,000 | +408.8% | 2,020 | +198.4% | 0.01% | +400.0% |
| Q4 2014 | $34,000 | +25.9% | 677 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $27,000 | -6.9% | 677 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $29,000 | -61.8% | 677 | -64.5% | 0.00% | -66.7% |
| Q1 2014 | $76,000 | +13.4% | 1,907 | -22.4% | 0.00% | 0.0% |
| Q4 2013 | $67,000 | +19.6% | 2,457 | 0.0% | 0.00% | +50.0% |
| Q3 2013 | $56,000 | – | 2,457 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 1,055,719 | $35,367,000 | 12.68% |
| GREAT POINT PARTNERS LLC | 828,253 | $27,746,000 | 5.70% |
| McClain Value Management LLC | 116,153 | $3,891,000 | 4.80% |
| Stonepine Capital Management, LLC | 231,913 | $7,769,000 | 4.63% |
| ARMISTICE CAPITAL, LLC | 228,000 | $7,638,000 | 1.81% |
| Opaleye Management Inc. | 90,000 | $3,015,000 | 1.78% |
| Matarin Capital Management, LLC | 257,268 | $8,618,478,000 | 0.97% |
| HAYS ADVISORY LLC | 116,939 | $3,917,000 | 0.87% |
| Granahan Investment Management | 496,025 | $16,617,000 | 0.57% |
| AlphaMark Advisors, LLC | 33,000 | $1,106,000 | 0.57% |